Omega Fund Management

Latest statistics and disclosures from Omega Fund Management's latest quarterly 13F-HR filing:

Companies in the Omega Fund Management portfolio as of March 2019 quarter

Company (Ticker) Portfolio Weight Share Count Change in Shares Price
Gossamer Bio Inc 48.31 6.95M NEW 21.67
Replimune Group Inc 24.82 5.10M 15.17
Translate Bio Inc 7.96 2.44M 10.19
Paratek Pharmaceuticals 4.47 2.60M 5.36
Obseva Sa 4.10 999364 12.79
Cymabay Therapeutics 2.35 551477 13.28
Fibrogen 2.28 130646 54.35
Cidara Therapeutics Inc Common Stock Usd 0.0001 1.28 1.51M 2.65
Essa Pharma Inc 1.19 1.08M 3.41
Jounce Therapeutics 1.05 529965 6.20
Pieris Pharmaceuticals 0.84 778230 3.35
Dicerna Pharmaceuticals 0.79 167157 14.65
Sienna Biopharmaceuticals Inc 0.56 758610 2.32

Past 13F-HR SEC Filings by Omega Fund Management

View All Filings